ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.90
      0.14%
      Bitcoin
      65,059.88
      -0.12%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. Nanobiotix (NANO)

      7. Nanobiotix (NANO) News

      NANO

      Nanobiotix (NANO)

      Nanobiotix
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:NANO
      DateTimeSourceHeadlineSymbolCompany
      01/22/20189:03AMCercle FinanceNanobiotix:titre bien orienté après des données prometteusesEU:NANONanobiotix
      01/22/20182:02AMGlobeNewswire Inc.NANOBIOTIX presents first promising data from Phase I/II Liver Cancers trial of NBTXR3 at the American Society Of Clinical On...EU:NANONanobiotix
      01/11/20184:15AMCercle FinanceNanobiotix: démarre une collaboration avec le ProvidenceEU:NANONanobiotix
      01/11/20182:08AMGlobeNewswire Inc.NANOBIOTIX partners with the Providence Cancer Institute to run immunotherapeutic preclinical research in pancreatic cancersEU:NANONanobiotix
      12/27/20171:34AMCercle FinanceNanobiotix: accord de la FDA pour un essai sur NBTXR3EU:NANONanobiotix
      12/26/20175:30PMGlobeNewswire Inc.NANOBIOTIX : FDA approves Nanobiotix's first Immuno-Oncology trialEU:NANONanobiotix
      12/26/20175:27PMGlobeNewswire Inc.NANOBIOTIX : 2017 review and 2018 expected milestonesEU:NANONanobiotix
      12/26/20172:50AMGlobeNewswire Inc.NANOBIOTIX : 2017 review and 2018 expected milestonesEU:NANONanobiotix
      12/26/20172:16AMGlobeNewswire Inc.NANOBIOTIX : FDA approves Nanobiotix's first Immuno-Oncology trialEU:NANONanobiotix
      11/16/20173:53AMCercle FinanceNanobiotix: recul du chiffre d'affaires au 3T.EU:NANONanobiotix
      11/13/20174:32AMCercle FinanceNanobiotix: données présentées à la SITC aux Etats-Unis.EU:NANONanobiotix
      11/13/20173:00AMCercle FinanceCalendrier des sociétés sur 15 joursEU:NANONanobiotix
      11/13/20172:02AMGlobeNewswire Inc.NANOBIOTIX presented new clinical and pre-clinical data confirming NBTXR3's significant potential role in Immuno-Oncology at ...EU:NANONanobiotix
      11/09/20172:14PMGlobeNewswire Inc.NANOBIOTIX provides update on the global development of its lead product NBTXR3EU:NANONanobiotix
      10/31/20175:05AMCercle FinanceNanobiotix: a placé des actions nouvelles à 14 euros.EU:NANONanobiotix
      10/23/20173:04AMCercle FinanceNanobiotix: inclusion de patients terminée pour un essai.EU:NANONanobiotix
      10/23/20172:01AMGlobeNewswire Inc.NANOBIOTIX completes patient inclusion for Phase II/III trial of NBTXR3 in soft tissue sarcomaEU:NANONanobiotix
      09/29/20172:45AMCercle FinanceNanobiotix: prévoit un nouvel essai clinique.EU:NANONanobiotix
      09/28/201712:31PMGlobeNewswire Inc.NANOBIOTIX plans to conduct its first clinical trial with NBTXR3 in combination with immune checkpoint inhibitors in the U.S....EU:NANONanobiotix
      09/13/20177:17AMCercle FinanceNanobiotix: JP Morgan AM dilué sous les 5% du capital.EU:NANONanobiotix
      08/31/20171:30PMGlobeNewswire Inc.NANOBIOTIX half year results for the six months ended 30 June 2017EU:NANONanobiotix
      08/28/20175:00AMCercle FinanceCalendrier des sociétés sur 15 joursEU:NANONanobiotix
      07/10/20172:48AMCercle FinanceCalendrier des sociétés sur 15 joursEU:NANONanobiotix
      06/16/20176:31AMCercle FinanceNanobiotix: JPMorgan AM s'est renforcé.EU:NANONanobiotix
      06/15/20173:45PMGlobeNewswire Inc.NANOBIOTIX : new translational data presented at ASTRO, NCI AND SITC'S Immunotherapy WorkshopEU:NANONanobiotix
      06/12/20172:56AMCercle FinanceCalendrier des sociétés sur 15 joursEU:NANONanobiotix
      06/09/20175:20AMCercle FinanceNanobiotix: JP Morgan AM se renforce au capital.EU:NANONanobiotix
      06/05/201712:01PMGlobeNewswire Inc.NANOBIOTIX : promising data from phase I/II Head and Neck cancer trial with NBTXR3 presented at the American Society of Clini...EU:NANONanobiotix
      05/18/20173:34AMCercle FinanceNanobiotix: bondit sur des données d'étude positives.EU:NANONanobiotix
      05/18/20171:59AMGlobeNewswire Inc.NANOBIOTIX announces first positive Human data showing that NBTXR3 could become a backbone in Immuno-OncologyEU:NANONanobiotix
       Showing the most relevant articles for your search:EU:NANO